Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04545502 · ClinicalTrials.gov registry record
PANTHER Study of Terumo Aortic Knitted and Woven Grafts, and Cardiovascular Patches
A clinical trial of Aortic Diseases and Aneurysm, sponsored by Vascutek.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 20
- Study locations
NCT04545502: Recruiting study of Aortic Diseases and Aneurysm, sponsored by Vascutek.
NCT04545502 is a study of Aortic Diseases and Aneurysm that is actively recruiting participants, run by Vascutek. The registered enrollment target is 2,000 participants, above the 1,266-participant average among 7 other Aortic Diseases trials with a reported enrollment target (58% higher). The trial reports 20 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04545502, a study of Aortic Diseases and Aneurysm, is actively recruiting participants, sponsored by Vascutek.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this registry is to collect safety and performance data on all commercially available Terumo Aortic knitted and woven grafts, and cardiovascular patches in standard clinical practice. Data will be collected both retrospectively and prospectively.
Primary Outcome
30 Day or In-Hospital Mortality
Conditions Studied
Interventions
- DEVICE Gelsoft Plus Vascular Graft
- DEVICE Vascular Bypass Graft
- DEVICE Cardiovascular Patch
- DEVICE Gelweave Vascular Graft
- DEVICE Gelweave Valsalva Vascular Graft
Study Locations (20)
Other
- UZ Gent - Ghent
- AZ Groeninge Kortrijk - Kortrijk
- UZ Leuven - Leuven
- CHU Bordeaux - Bordeaux
- CHU Clermont Ferrand - Clermont-Ferrand
- CHU de Dijon - Dijon
- CHU de Lille - Lille
- Hôpital Nord Marseille - Marseille
- CHU de Rennes - Rennes
North Carolina
- Duke University - Durham
- East Carolina University - Greenville
Ohio
- University Hospitals Cleveland Medical Center - Cleveland
- Ohio State University - Columbus
Pennsylvania
- Lehigh Valley Hospital - Allentown
- University of Pennsylvania - Philadelphia
Colorado
- University of Colorado Anschutz - Aurora
Florida
- University of South Florida - Tampa General - Tampa
Indiana
- Indiana University Health - Indianapolis
Virginia
- Virginia Commonwealth University - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2021-02-17 |
| Est. Completion | 2037-01 |
What NCT04545502 shows while recruiting
NCT04545502 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,266-participant average among 7 other Aortic Diseases trials with a reported enrollment target (58% higher).
The record links to 9 conditions, with Aortic Diseases appearing as the primary indexed condition, and to 5 interventions - of which Gelsoft Plus Vascular Graft is the first listed.
NCT04545502 names 20 study sites across 9 states, led by Other, North Carolina, Ohio.
Frequently Asked Questions
What is clinical trial NCT04545502 about?
NCT04545502 is a clinical study titled "PANTHER Study of Terumo Aortic Knitted and Woven Grafts, and Cardiovascular Patches". The purpose of this registry is to collect safety and performance data on all commercially available Terumo Aortic knitted and woven grafts, and cardiovascular patches in standard clinical practice. Data will be collected both retrospectively and prospectively.
What is the current status of trial NCT04545502?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2021-02-17. Estimated completion is 2037-01.
What conditions does trial NCT04545502 study?
This clinical trial studies the following conditions: Aortic Diseases, Aneurysm, Dissection, Aortic Root Aneurysm, Aortic Root Dissection.
What interventions are being tested in trial NCT04545502?
The interventions under investigation include: Gelsoft Plus Vascular Graft (DEVICE), Vascular Bypass Graft (DEVICE), Cardiovascular Patch (DEVICE), Gelweave Vascular Graft (DEVICE), Gelweave Valsalva Vascular Graft (DEVICE).
Who is sponsoring clinical trial NCT04545502?
This trial is sponsored by Vascutek, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04545502 being conducted?
This trial has 20 study locations across Colorado, Florida, Indiana, North Carolina, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the Aorta
RECRUITING · NA
-
Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR
RECRUITING · NA
-
Montalcino Aortic Consortium: Precision Medicine for Heritable Thoracic Aortic Disease
RECRUITING
-
Intervascular Post-Market Clinical Follow-Up (PMCF) Registry
RECRUITING
-
Liposomal Bupivacaine/Bupivacaine in Rectus Sheath Blocks Versus Ropivacaine in Rectus Sheath Blocks And Catheters
RECRUITING · Phase 4
-
Development of CIRC Technologies
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI